Epstein–Barr virus strain heterogeneity impairs human T-cell immunity

T cells for viral infections after allogeneic hematopoietic stem cell transplant

(2016) Catherine M. Bollard et al.   BLOOD

Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections

(2016) R J O'Reilly et al.   BONE MARROW TRANSPLANTATION

Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring

(2016) Nina Körber et al.   Journal of Translational Medicine

T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

(2015) Jamie Rossjohn et al.   Annual Review of Immunology

The Immunology of Epstein-Barr Virus–Induced Disease

(2015) Graham S. Taylor et al.   Annual Review of Immunology

Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8 + T Cell Response by Selection of Altered Epitope Processing

(2015) Andreas Walker et al.   JOURNAL OF VIROLOGY

Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection

(2015) Anne L. Palser et al.   JOURNAL OF VIROLOGY

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells

(2015) Chiara Rancan et al.   PLoS Pathogens

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein–Barr virus-specific T cells as targets of interest in immunotherapeutic approaches

(2014) Sabine Tischer et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Genomic Diversity of Epstein-Barr Virus Genomes Isolated from Primary Nasopharyngeal Carcinoma Biopsy Samples

(2014) H. Kwok et al.   JOURNAL OF VIROLOGY

Designing the epitope flanking regions for optimal generation of CTL epitopes

(2014) Nicholas J. Steers et al.   VACCINE

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

(2013) Catherine M. Bollard et al.   JOURNAL OF CLINICAL ONCOLOGY

A peptide's perspective on antigen presentation to the immune system

(2013) Jacques Neefjes et al.   Nature Chemical Biology

Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas

(2013) Ming-Han Tsai et al.   Cell Reports

Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough

(2013) Christopher J. Holland et al.   Frontiers in Immunology

GILT: Shaping the MHC Class II-Restricted Peptidome and CD4+ T Cell-Mediated Immunity

(2013) Karen Taraszka Hastings   Frontiers in Immunology

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

(2012) Vanya Icheva et al.   JOURNAL OF CLINICAL ONCOLOGY

Improving T-Cell Therapy for Epstein-Barr Virus Lymphoproliferative Disorders

(2012) Catherine M. Bollard   JOURNAL OF CLINICAL ONCOLOGY

Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4+ T-cell repertoire selection

(2012) David K. Cole et al.   Nature Communications

Immune defence against EBV and EBV-associated disease

(2011) Heather M Long et al.   CURRENT OPINION IN IMMUNOLOGY

Immunotherapy for EBV-associated malignancies

(2011) Anna Merlo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease

(2009) K. A. McAulay et al.   JOURNAL OF IMMUNOLOGY

The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal

(2009) Cindy M. Chang et al.   VIRUS RESEARCH